Saturday 17 October 2026
Export DARE’s income statement to Excel — free account
Dare Bioscience, Inc.
DARE Healthcare Biotechnology
Dare Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, up 10,412.2% from fiscal 2024. In the quarter to June 2026, revenue grew 984.4%, EPS grew 55.6% and free cash flow fell 30.2%, each against the same quarter a year earlier.
0.72
0.02
−2.70%
Follow DARE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 4 | 4 | — |
+8 more TTM periods Free account |
| 165.29% | 272.28% | 845.52% | (2,543.18%) | ||
| (62.16%) | (51.76%) | (49.10%) | (71.56%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(928.44%) | (604.34%) | (271.40%) | (320.73%) | |
Average Days of Receivables |
121.95 | 216.92 | 203.05 | (2,360.03) | |
Free Cash Flow per Share |
(0.78) | (0.68) | (0.92) | (0.53) | |
Free Cash Flow |
(11.60) | (9.94) | (10.27) | (6.77) | |
Capital Expenditures |
(0.31) | — | (0.39) | (0.74) | |
| Other line items | |||||
Cash ROIC |
(96.22%) | (51.60%) | (37.28%) | (25.92%) | |
Accounts Receivable Turnover |
4.24 | 2.92 | 2.57 | (0.13) | |
Accounts Payable Turnover |
0.46 | 0.17 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
479.19 | 1,696.95 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
197.64% | 335.82% | 536.15% | (14,426.44%) | |
Selling, General and Administrative Expense of Revenue |
652.90% | 751.99% | 850.65% | (16,081.26%) | |
Share Based Compensation of Revenue |
109.95% | 136.03% | 145.27% | (2,852.36%) | |
Operating CF/Net income |
1.03 | 0.83 | 0.74 | 0.34 | |
Depreciation/Fixed assets |
1.50 | 1.39 | 1.05 | 0.74 | |
Capex/Depreciation |
(0.14) | 0.00 | (0.24) | (0.61) | |
Revenue per Share |
0.09 | 0.08 | 0.09 | 0.00 | |
Operating CF per Share |
(0.76) | (0.68) | (0.88) | (0.47) | |
Capex per Share |
(0.02) | 0.00 | (0.03) | (0.06) | |
Capex to Sales |
0.23 | 0.00 | 0.37 | (12.98) |
Columns are period end dates